Close Menu

NEW YORK (GenomeWeb) – Mobidiag, a Finnish molecular diagnostics maker, has entered an agreement with Chinese clinical diagnostics firm Autobio Diagnostics to establish a joint venture in China. Separately, Autobio Diagnostics has made a €10 million ($11.3 million) equity investment in Mobidiag, the firms announced today.

Mobidiag and Autobio will invest a total of €12.3 million to establish the joint venture company, with Autobio investing €8 million in the JV for a 65 percent stake, and Mobidiag investing €4.3 million for a 35 percent stake. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

One gene regulates hundreds of others to influence facial development, according to New Scientist.

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.

Dec
17
Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.